Products
News
Resources
Contact
Language
简体中文
繁體中文
English
日本語
한국어
Tiếng Việt
Overview
Latest
Regional
Industry
Featured
Multimedia
Other Languages
Public Company News
All
APAC
Global
All
APAC
Global
All
APAC
Global
All
APAC
Global
{{toptitleLeft}}
{{toptitleRight}}
{{selectTitle}}
{{toptitleLeft}}
{{index}}
{{select_list_per.name}}
Time
{{showName}}
{{weixin_name}}
X
{{listname}}
Loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.headline}}
{{storydata.create_time}}
{{storydata.headline}}
{{storydata.create_time}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
loading
The End
Network Errors Please Retry
loading
Network Errors Please Retry
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
{{storydata.story.headline}}
{{storydata.story.date_time}}
{{storydata.story.click_num}}
{{theme.pcom_theme_name}}
loading
The End
Network Errors Please Retry
Complete Genomics Drops Genome Sequencing Price to Sub $100 at AGBT General Meeting
2023-02-07 22:00
J INTS BIO, Oral TKI 'JIN-A04', poster presentation of HER2 exon20 insertion mutation in NSCLC
2023-02-07 12:23
Hinova Receives FDA Proceed Authorization for its IND Application for HP518, an Orally Bioavailable Chimeric Degrader Targeting Androgen Receptor for Prostate Cancer Treatment
2023-02-06 21:10
Inmagene receives IND clearance for IMG-008, a long-acting IL-36R mAb
2023-02-06 18:00
Ground-breaking results in Phase 2 scleroderma study by Certa Therapeutics demonstrates improvement in more than 60% of patients
2023-02-06 13:01
Gracell Biotechnologies Announces FDA Clearance of the IND Application for Phase 1b/2 Clinical Trial of FasTCAR-T GC012F for the Treatment of Relapsed/Refractory Multiple Myeloma
2023-02-03 20:30
BriSTAR Immunotech to Present at the BIO CEO & Investor Conference
2023-02-02 19:37
CN Energy Group. Inc. Announces Closing of $10 Million Underwritten Public Offering
2023-02-01 22:59
HanAll Biopharma Reports Full-Year 2022 Results and Provides Business Update
2023-02-01 20:00
CARsgen Announces Collaboration Agreement to Evaluate AB011 in Combination with PD-L1 Checkpoint Inhibitor to Treat Gastric Cancer
2023-01-31 21:50
Appendix 4C - Q2 FY23 Quarterly Cash Flow Report
2023-01-31 20:25
Singleron to present single cell sequencing solutions at the 36th Molecular Biology of Plants Conference
2023-01-31 16:00
Oricell Publishes Data from POLARIS Clinical Study Evaluating OriCAR-017 in the Treatment of RRMM in The Lancet Haematology
2023-01-31 09:24
Help Therapeutics Announces IND Approval of First Universal iPSC-derived Cardiomyocyte Therapy for End-stage Heart Failure in China
2023-01-30 23:00
Alpha Biopharma Submits New Drug Application for Zorifertinib, a Next-Generation EGFR-TKI to Treat EGFR-mutated NSCLC Patients with CNS Metastases
2023-01-30 10:00
SK bioscience Introduces New Partnership Model to Establish Regional Vaccine Hubs
2023-01-27 20:00
Samsung Biologics Reports Fourth Quarter & Fiscal Year 2022 Financial Results
2023-01-27 14:52
ReLive Biotechnologies, Ltd. Completes Asset Purchase of Co.Don AG and Series A Financing Led By SHC, Furthering its Ambition to Become the Global Leader in Regenerative Therapies
2023-01-26 12:11
iNtRON has confirmed the efficacy of BAL200, a novel endolysin biologic for Inhalational Anthrax
2023-01-26 10:34
HBM Alpha Therapeutics Raises Seed Round to Advance Next-Gen Therapies for Endocrine Disorders
2023-01-26 09:22
1
61
62
63
64
65
222